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Barrie r perturbation stimulates epidermal cholesterol syn-
thesis, which plays an important role in restoring barrie r 
function. In the present study, we examined whether 
changes in serum cholesterol levels or nutrition regulate epi-
dermal cholesterol synthesis in h airless mice. Serum choles-
terol levels were lowered by 50% after injection with 4-
aminopyrazolo (3 ,4-d) pyrimidine and were increased by 
51 % by feeding an atherogenic diet. In contras t to most other 
tissues, cholesterol synthesis in the epidermis and dermis w as 
not inhibited by elevations or stimulated by decreases in 
serum cholesterol levels. Additionally, feeding a high-cho-
lesterol diet did not decrease epidermal or dermal cholesterol 
A primary function of the skin is to provide a barrier against excessive water loss. Stratum corneum extra-cellular lipids, comprised primarily of cholesterol, cerami des, and fatty acids, are essential components of this barrier [1,2]' The epidermis is a very active site of 
cholesterol synthesis that provides the cholesterol required for the 
stratum corneum permeability barrier [3,4] . Acute disruption of the 
barrier stimulates epidermal cholesterol synthesis with cholesterol 
synthesis returning towards normal in parallel with the restoration 
of barrier function [5] . Moreover, essential fatty acid deficiency, a 
chronic model of barrier disruption, also increases epidermal cho-
lesterol synthesis [6,7] . Furthermore, in both acute and chronic 
models of barrier disruption, occlusion with a water vapor-
impermeable membrane artificially corrects barrier function and 
prevents the increase in cholesterol synthesis [3,7]. 
Although these data indicate that epidermal cholesterol synthesis 
is regulated by barrier function, whether epidermal cholesterol syn-
thesis is also regulated by alterations in serum cholesterol levels is 
unclear. Whereas differentiating keratinocytes in culture display a 
paucity of low-density lipoprotein (LDL) recet>tors, proliferating 
cultured keratinocytes elaborate LDL receptors [8 - 10J and exhibit 
feedback regulation of sterologenesis in response to exogenous LDL 
[10 -12]. Thus, these cells are potentially susceptible to changes in 
circulating cholesterol levels. In many tissues, decreasing serum 
cholesterol level has been shown to stimulate cholesterol synthesis 
although , conversely, increasing serum cholesterol level inhibits 
cholesterol synthesis [13 ,14]. Both responses appear to be mediated 
by LDL receptors on the surface of cells in these tissues. However, 
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synthesis. However, fastin g significantly decreased both epi-
d ermal (38% ) and dermal (34% ) cholesterologenesis. Fur-
thermore, barrier recovery after aceton e disruption of the 
barrier was impaired in fasted animals. However, treatment 
with topical lipids did not restore barrier repair rate to nor-
mal, indicating that factors in addition to lipids are necessary 
to overcome the effects of fasting. These results demonstrate 
that cholesterol synthesis in the epidermis and dermis is reg-
ulated independently of changes in serum cholesterol levels. 
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cholesterol synthesis in some tissues, such as smooth muscle and 
cardiac muscle, is insensitive to changes in serum cholesterol levels 
[13 ,14]. 
Thus, one goal of this study was to determine the relationship 
between serum cholesterol levels and th e rate of cholesterol synthe-
sis in the epidermis and dermis. Serum cholesterol levels were low-
ered with 4-aminopyrazolo (3,4-d) pyrimidine (4-APP) [15 ,16], or 
elevated by feeding an atherogenic diet [17]. In addition, we deter-
mined whether factors other than changes in serum cholesterol 
levels, such as fasting, regul ate epidermal and dermal cholesterol 
synthesis. Whereas we found that changes in serum choles-
terollevels did not regulate epidermal or dermal cholesterol synthe-
sis, fasting decreased cutaneous cholesterol synthesis. 
MATERIALS AND METHODS 
Materials Male hairless mice (Hr/ Hr), 8 - 12 weeks old, were purchased 
from Simonsen Laboratories (Gilroy, CAl or Charles River (Cambridge, 
MA).; 4-APP, bovine cerami des type IV, linoleic acid, propylene glycol, and 
chollc aCid were purchased from Sigma Chemicals (St. Louis, MO); lard was 
purchased from ICN Biochemicals (Cleveland, OH); petroleum ether and 
acetone were purchased from Fisher Scientific (Fairlawn, N]); [3H)H20 and [14C) cholesterol were purchased from New England Nuclear Research 
Products (Boston, MA); cholesterol was purchased from Nutritional Bio-
chemicals (Cleveland, OH); and sil ica G TLC plates were purchased from 
Brinkmann Instruments (Westbury, NY). 
Animal Procedures To decrease serum cholesterol levels, mice were 
injected with 4-APP, which il1hibits hepatic secretion of lipoproteins and 
thereby lowers serum cholesterol concentrations [15,1 6). Mice were injected 
intraperitoneally with 0.8 mg of 4-APP suspended in 0.2 ml phosphate 
buffer (PH 4). A control group of animals were similarly injected with buffer 
alone. Both groups of animals were fasted during the study because 4-APP 
can cause anorexia. To increase serum cholesterol concentrations, mice were 
fed an atherogenic diet containing 5% lard, 2% cholesterol, and 0.3% cholic 
acid in powdered rodent chow [1 7). Control mice were fed powdered rodent 
chow alone. The barrier was disrupted by wiping with absolute acetone until 
transepidermal waterloss (TEWL) reached 5-9 mg/cm2/h (normal < 0.15 
mg/cm2/ h) [5,7). Barrier function. assessed as TEWL, was determined with 
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Table I. Serum Lipid Concentrations" 
Treatment Serum Cholesterol (mg/dl) 
Fasting (n = 20) 
Fasting, 4-APP (n = 5) 
Fed (n = 15) 
Fed, atherogenic (n = 10) 
105 ± 4 
53 ±4b 
103 ± 5 
156 ± 5' 
• Mice either fasted for 1 or 2 d, or fed ad libilllm. Because serum cholesterollcvcls of 
all groups of fasting mice were similar they were pooled. Fasting, 4-APP - treated mice 
were injected with 0.8 mg 4-APP in phosphate buffer one day prior to sampling. Fed 
mice were fed normal rodent chow. Fed, atherogenic mice were fcd an atherogenic diet 
for 7 d. Serum cholesterol levels were measured using Sigma Diagnostic kit for choles-
terol (mean ± SEM). 
• P < 0.01 compared to fasting. 
, p < 0.01 compared to fed. 
a Meeco Electrolytic Water Analyzer (MEECO, Warrington, PA) [5,7]. 
Topical lipids were applied to acetone-trea ted skin (0.5 mg cholesterol, 0.25 
mg ceramides, 0.2 mg linoleic acid in polyethylene glycol : ethanol; 7: 3 
vols; SO /.li/5 cm2 ) , as previously described [IS]. This lipid mixture was 
shown previously to neither accelerate nor delay barrier recovery in acetone-
treated hairless mice [IS] . 
Cutaneous Sterologenesis Incorporation of [3H)H20 into cutaneous 
cholesterol was determined as described previously [4 -6]. Briefly, each 
animal was injected with 20 mCi/0.2 ml [3H)H20 intraperitoneally. After 2 
h, the animals were killed and the skin was removed. Subcutaneous fat was 
removed, the skin was weighed and then exposed to dry heat at 60·C for 60 
seconds, and the epidermic and dermis were isolated by scraping with a 
number 22 blade. T he epidermis and dermis were dissolved separately in a 
saponification solution (45% KOH, water, 95% ethanol; 4: 3: 10 vols) by 
incubating at 60 · C for at least 3 h. After an internal standard [14C) choles-
terol (approximately 2000 cpms) was added to each sample the cholesterol 
was extracted with petroleum ether. The extracts were spotted on TLC 
plates and developed in ethyl acetate : benzene (1 : 5 vols) for 90 min. Bands 
corresponding to cholesterol were excised and counted. Because of varia-
rions in the rate of cholesterol synthesis from month to month, only animals 
studied during the same period were compared. 
Serum Lipid Levels Serum cholesterol concentrations were measured 
using the Sigma Diagnostic Kit number 352. 
Statistics Statistical significance was determined using the Student test for 
two-way comparisons. Analysis of variance was used to compare treatments 
as a function of time. Values of less than 0.05 were considered to be statisti-
ca lly significant. 
RESULTS 
To determine the effects of lowering seru m cho lesterol on cutane-
ous cho lesterol synthesis, hairless mice were injected with ei ther 
buffer or 4-APP to lower serum cholesterol levels, and then studied 
1 d later. Because 4-APP causes anorexia, both the 4-APP-treated 
animals and controls were fas ted . Serum cho lesterol levels were 
decreased by a mean of 50% in 4-APP treated mice (p < 0.01) 
(Table I). Neither epidermal nor dermal cholesterol synthesis were 
altered in 4-APP-treated mice (Fig 1). 
To determine the effects of increasing serum cholesterol concen-
trations on cutaneOllS cho lesterol synthesis, mice were fed an ather-
ogenic diet fo r 7 d. As shown in Table I, the atherogenic diet 
increased serum cholesterol concentrations by 51% (p < 0.01). 
However, cholesterol synthesis in both the epidermis and dermis 
remained unchanged in mice fed the atherogenic diet (Fig 2). Thus, 
in contrast to most other tissues that are regulated by serum cho les-
terol levels, alterations in serum cholesterol levels do not regulate 
either epidermal or dermal cholesterol synthesis. 
We next determined the ro le o f acute starvation in regulating 
cutaneous cholesterol synthesis. Serum cholesterollexels were sim-
il ar in fed animals and animals fasting for 2 d (Table I) . However, 
epidermal cholesterol (38%) synthesis and dermal cholesterol 
(34%) synthesis were decreased in fasting mice (Fig 3) (p < 0.05). 
Thus, acute starvation decreases cutaneous cho lesterol synthesis. 
Previolls studies have demonstrated that epidermal cho lesterol 
synthesis plays a crucial ro le in barrier repair after acute disruption 
by acetone treatment [3,19]. We next determined whether the re-
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Figure 1. C holesterol synthesis in 4-APP - treated mice. 4-APP mice were 
injected with O.S mg 4-APP in phosphate buffer and control mice were 
injected with phosphate buffer alone one day prior to study. Both control 
and 4-APP animals fasted after 4-APP administration. On the day of the 
study, the mice were injected with [3H]H20 and killed 2 h later, and plasma 
and skin samples were obtained. The epidermis was separated from the 
dermis and [3H)H20 incorporation into lipid determined (jlmoles incorpo-
rated/g tissue/2 h) as described in Materials alld Meth ods. Values shown are 
the mean ± SEM (n = 5). 
duction in cholesterol synth esis that accompanies fast ing might 
compromise barrier repair. As shown i11 Fig 4, barrier repair is im-
paired i11 fasting versus control animals. Six hours after acetone 
treatment, TEWL rates are 41 % higher in fasting mice (p < 0.01), 
indicatin g that barrier repair is compromised in fasting animals. By 
24 h after barrier disruption, TEWL had returned to normal in both 
fasting and fed animals (data not shown). Finally, topical application 
of cho lesterol alone or a mixture of stratum corneum lipids (choles-
terol, ceramides, and lino leic acid) did n ot normalize barrier recov-
ery rate in fasting mice (after 6 h , vehicle TEWL = 4.24 ± 1.28; 
lipid TEWL = 5.00 ± 1.05 mg/cm2/h, n = 5) . 
DISCUSSION 
Permeability barrier functio n is an important determinant of the 
rate of epidermal cholesterol synthesis [3 ,5 - 7]. The effect of alter-
ations in serum cholesterol levels on epidermal cholesterol synthesis 
has not been closely examined . Decreased serum ch olesterol con-
centrations stimulate cho lesterol synthesis in the rat adrenal gland, 
liver, lung, kidney, intestine, brain, adipose tissue, and ovary 
[13 ,14,20] and in the hamster adrenal cortex [21] . Conversely, in-
creases in serum cholesterol levels inhibit cho lesterol synthesis in 
fed con t rol 
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Figure 2. Cholesterol synthesis in mice fed an atherogenic diet. Mice were 
fed control rodent chow or atherogenic chow ad libitllm for 7 d. On the day 
of the study, the mice were injected with [3H)H20 and killed 2 h later, and 
plasma and skin samples were obtained. T he epidermis was separated from 
the dermis, and [3H)H20 incorporation into lipids (jlmoles incorporated/g 
tissue/2 h) determined as described in Materials alld Methods. Values shown 
are the mean ± SEM (controln = 15; atherogenic n = 10). 
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Figure 3. Cholesterol synthesis in fasting and fed mice. Mice were fed 
normal rodent chow ad libiwl/I or fasted for 2 d. On the day of the study, the 
mice were injected with [3H]H20 and ki lled 2 h later, and plasma and sk1l1 
samples were obtained. The epidermis was separated from the. dermiS, and 
[3H]H20 incorporation determined (,umoles i!1corporated/g tlSsue/2 h) as 
described 111 Materials Mid Methods. ·Statlstlcal difference compared to control 
(p < 0.05). Values shown are the mean ± SEM (n = 15). 
most of these same tissues [13,14] . Large increases in serum choles-
terol levels produced by lipoprotein infusion decreased cholesterol 
synthesis in whole skin [13] , whereas decreasing serum cholesterol 
levels had no effect on cutaneous cholesterol synthesis in rats 
[13,20]. However, because the epidermis comprises no. more than 
10% of the total skin mass and accounts for a nunonty of total 
cutaneous sterologenesis [4], significant changes in epidermal cho-
lesterol synthesis could be overlooked when cholesterol synthesis is 
measured in whole skin alone. Thus, the aim of the present study 
was to determine the effect of increases or decreases in serum cho-
lesterol concentrations on epidermal and dermal cholesterol syn-
thesis. 
No significant changes were observed in cholesterol synthesis in 
the epidermis or dermis of mice with either high or low serum 
cholesterol levels (Figs 1 and 2) . Therefore, as 111 the whole sk1l1, 
both epidermal and dermal cholesterol synthesis appears to be regu-
lated independent of changes in serum cholesterol levels. Either the 
absence of significant numbers of functiona l LDL receptors in the 
epidermis [22] , an~/or the inaccessibility of serum lipoproteins to a 
significant proportion of the cells that syntheSize cholesterol, cou ld 
account for these findings. 
In addition, we determined the effect of feeding a high-choles-
terol diet on cutaneous cholesterol synthesis. Feeding a diet supple-
mented with 5% cholesterol did not decrease whole skin sterol 
synthesis [23] . Likewise, a high-fat, high-cholesterol diet also had 
no effect on epidermal or dermal cholesterol syntheSIS (Fig 2). 
We next examined the effect of fasting on cutaneous cholesterol 
synthesis. Fasting decreases cholesterol synthesis in the kidney, 
liver, and intestine [14,23] . In the skin, others have reported either a 
decrease [24] or no change [14,23] in cutaneous cholesterol synthe-
sis with starvation. In our studies, fasting decreased both epidermal 
and dermal cholesterol by 34 -38% (Fig 3) (p < 0.05) . The mecha-
nism by which fasting inhibits cholesterol synthesis in the skin or 
other organs in unknown but may be related to decreases in ATP 
levels. Recent studies have shown that decreased ATP levels result 
in the phosphorylation and inactivation of HMG CoA reductase, 
the rate- limiting enzyme in cholesterol synthesis [25] . 
Inhibition of cholesterol synthesis due to fasting resulted in an 
impairment of barrier recovery (Fig 4) . These data are consistent 
with previous studies that demonstrated that inhibition of choles-
terol synthesis by lovastatin results in delayed barrier recovery, 
which is reversed by topical co-application of cholesterol [19] . 
However, topical cholesterol in this study did not restore barrier 
recovery, suggesting that the effects of fasting on the epidermis are 
complex, and that factors in addition to lipids are necessary to over-
come the effects of acute starvation. Because fasting induces a cata-, 
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Figure 4. Barrier recovery in fasting mice. Mice were fed rodent chow ad 
libitul/l or fasted for 2 d and then treated with acetone to disrupt the barrier. 
TEWL was measured over 6 h. Values shown are the mean percent of 
maximum TEWL ± SEM (n = 7). Analysis of variance was used to deter-
mine statistical difference between groups over time (p < 0.01). 
bolic state, many anabolic processes in addition to cholesterol syn-
thesis may be inhibited . Starvation is well known to impair wound 
healing [26,27)' but despite intensive investigation, the reasons for 
this inhibition are unknown. If the regulation of epiderma.l choles-
terol synthesis is similar in humans, then patients suffering from 
malnourishment or starvation could display abnormal permeability 
to drugs or xenobiotics, defective wound healing, and increased 
susceptibility to the effects of dehydration or skin infections. 
A number of pathophysiologic states also affect cholesterol syn-
thesis in the skin. For example, in ketoacidotic diabetic animals and 
humans, cutaneous cholesterol synthesis decreases in comparison to 
nondiabetic controls [28,29)' and increases with insulin administra-
tion [24,30]. In addition, epidermal cholesterol synthesis is de-
creased in rats that are hypothyroid [31]. Whether barrier homeo-
stasis or repair are impaired in one or more of these disease states 
remains to be determined. 
In summary, the data presented in this study demonstrate that 
epidermal and dermal cholesterol synth esis are autonomous of 
changes in serum cholesterol levels and high-cholesterol diets, but 
are decreased by fasting . 
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